Earnings Feed
Start Free
Home/Filings/4/0000914190-09-000164
4//SEC Filing

CARDIOVASCULAR SYSTEMS INC 4

Accession 0000914190-09-000164

CIK 0001222929operating
View on SEC.govCompany Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 1:58 PM ET

Size

15.2 KB

Accession

0000914190-09-000164

Insider Transaction Report

Form 4
Period: 2009-02-25
CARDIOVASCULAR SYSTEMS INCNONE
EASTON CAPITAL PARTNERS L P
10% Owner
Transactions
  • Other

    Warrant

    2009-02-25+234,339→ 234,339 total
    Exercise: $5.71From: 2009-02-25Exp: 2014-02-24→ Common Stock (234,339 underlying)
  • Other

    Warrant

    2009-02-25+234,339→ 234,339 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
    Exercise: $5.71From: 2009-02-25Exp: 2014-02-24→ Common Stock (234,339 underlying)
Holdings

  • Warrant

    (indirect: Held by Easton Hunt Capital Partners, L.P.)
    Exercise: $5.71From: 2006-07-19Exp: 2011-07-19→ Series A Conv Preferred Stock (87,499 underlying)
    87,499

  • Series A Conv Preferred Stock

    → Common Stock (616,197 underlying)
    616,197

  • Series A Conv Preferred Stock

    (indirect: Held by Easton Hunt Capital Partners, L.P.)
    → Common Stock (616,197 underlying)
    616,197

  • Warrant

    (indirect: Held by Easton Hunt Capital Partners, L.P.)
    Exercise: $6.00From: 2008-09-12Exp: 2013-09-12→ Common Stock (166,667 underlying)
    166,667

  • Warrant

    Exercise: $5.71From: 2006-07-19Exp: 2011-07-19→ Series A Conv Preferred Stock (87,499 underlying)
    87,499
Footnotes (2)
  • [F1]Each share of Series A convertible preferred stock is convertible at any time, at the holder's election, into 1.01 shares of common stock and has no expiration date.
  • [F2]Holders of approximately 68% of the outstanding preferred stock entered into an agreement with the Company whereby effective immediately prior to the effective time of the merger of the Company with Replidyne, Inc., all preferred stock will convert into shares of common stock. The warrants were issued pro rata to each preferred shareholder, based on the percentage of preferred stock held, in consideration for entering into such conversion agreement.

Documents

1 file

Issuer

CARDIOVASCULAR SYSTEMS INC

CIK 0001222929

→
Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0001222929

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 1:58 PM ET
Size
15.2 KB
View on SEC.gov